Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Respirology (Carlton, Vic.)
|
April 21, 2020
Is corticosteroid use truly not associated with improved outcomes in AE-IPF? - Reply
Erica Farrand, Harold R Collard
Clinics in Chest Medicine
|
May 24, 2021
Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems
Erica Farrand, Andrew H Limper
Thorax
|
September 12, 2021
Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination
Alison M DeDent, Erica Farrand
Current Opinion in Pulmonary Medicine
|
May 16, 2023
Digital outcome measures in pulmonary clinical trials
Erica Farrand, Jeffrey J Swigris
Journal of Hospital Medicine
|
July 13, 2017
The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer
Erica Farrand, Rupal Shah, Harold Collard
Respirology (Carlton, Vic.)
|
June 2, 2024
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
Kavya Koshy, Hayley Barnes, Erica Farrand, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 25, 2026
From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation
Erica Farrand, Paul J Wolters, Christine Kim Garcia, et al.
Respirology (Carlton, Vic.)
|
December 18, 2019
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Erica Farrand, Eric Vittinghoff, Brett Ley, et al.
Implementation Science : IS
|
February 1, 2022
Addressing health disparities through implementation science-a need to integrate an equity lens from the outset
Andrew D Kerkhoff, Erica Farrand, Carina Marquez, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 21, 2023
Machine-Learning Algorithm to Improve Cohort Identification in Interstitial Lung Disease
Erica Farrand, Oksana Gologorskaya, Hunter Mills, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Respirology (Carlton, Vic.)
|
April 21, 2020
Is corticosteroid use truly not associated with improved outcomes in AE-IPF? - Reply
Erica Farrand, Harold R Collard
Clinics in Chest Medicine
|
May 24, 2021
Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems
Erica Farrand, Andrew H Limper
Thorax
|
September 12, 2021
Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination
Alison M DeDent, Erica Farrand
Current Opinion in Pulmonary Medicine
|
May 16, 2023
Digital outcome measures in pulmonary clinical trials
Erica Farrand, Jeffrey J Swigris
Journal of Hospital Medicine
|
July 13, 2017
The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer
Erica Farrand, Rupal Shah, Harold Collard
Respirology (Carlton, Vic.)
|
June 2, 2024
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
Kavya Koshy, Hayley Barnes, Erica Farrand, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 25, 2026
From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation
Erica Farrand, Paul J Wolters, Christine Kim Garcia, et al.
Respirology (Carlton, Vic.)
|
December 18, 2019
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Erica Farrand, Eric Vittinghoff, Brett Ley, et al.
Implementation Science : IS
|
February 1, 2022
Addressing health disparities through implementation science-a need to integrate an equity lens from the outset
Andrew D Kerkhoff, Erica Farrand, Carina Marquez, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 21, 2023
Machine-Learning Algorithm to Improve Cohort Identification in Interstitial Lung Disease
Erica Farrand, Oksana Gologorskaya, Hunter Mills, et al.
Page
of 3